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Reducing Healthcare Professionals’ Stigma
Toward Persons with Opioid Use Disorder

Quality Improvement (QI) Project

Denise Bouchard, DNP student, USM / Dr. Trip Gardner, MD, mentor

Abstract: Only one in five who need treatment for opioid use disorder
(OUD) in the U.S. receive it despite effective treatments (1). A root cause
analysis was undertaken for this quality improvement (QI) project to
determine causes for undertreatment of OUD. Healthcare professional
stigma emerged as a recurrent theme affecting availability of services
and help-seeking behaviors among those with OUD. Two stigmareduction workshops were held, one year apart, at two rural Maine hospitals.
A validated questionnaire was used pre- and 6-12 weeks post-intervention
which showed a statistically significant decrease in total stigma, attitude, and
social distance scores, with a non-significant decrease in help-seeking /
disclosure scores.

Results:
Qualitative (N = 19): Objectives: met; Ideas Presented: relevant; Learning:
effective; Knowledge: increased, should be repeated
Comments: ‘very good’, ‘great’, ‘interactive’, ‘multidisciplinary’, ‘awesome’,
‘very needed’, ‘should be mandatory’
Quantitative (N = 13): see Figure 1 & Figure 2

Figure 1. Total Stigma Score: OMS-HC
(revised for OUD)

Background:
* Maine: 1 of top 10 states with the highest opioid-related deaths (2)
* mid-coast Maine averaged 16.4 drug-related overdose deaths per 10,000
residents in 2017 (3)
* high levels of stigma toward persons with OUD (4) contribute to low
quality care and limited access to treatment (5)
* Understanding Stigma anti-stigma program targets healthcare providers (6)

Mean Stigma Score

38.31

Methods:
Context: Plan-Do-Study-Act (PDSA) process

Qualitative: post-intervention evaluations to measure participant’s perceptions of
intervention effectiveness.
Analysis: normality reasonably met for 4 variables (> .05) on KolmogorovSmirnov and Shapiro-Wilk / parametric paired t-tests used
Discussion:
* intervention reduced healthcare professionals opioid use disorder-related stigma
* not enough prescribers (N = 3) to determine change in willingness to prescribe
buprenorphine
* despite small number of completed measures (N = 13), results still encouraging due
to significance and large effect size for three of the measures

Post

Total stigma scores from Time 1 (M = 38.31, SD = 8.70) to
Time 2 (M = 30.54, SD = 8.12), t (12) = 3.794, p = .003 (two-tailed)

Similar results to Khenti, Bobbili, & Sapag (7): reduction of stigmatizing attitudes

Figure 2. Subscale Scores: OMS-HC
(revised for OUD)

Complementary to Knaak et al.’s (8): mixed model analysis which showed
statistically significant improvement for all OMS-HC scores

14.54

Sites: community health center (Federally Qualified Health Center, FQHC)
& 2 hospitals in rural mid-coast Maine
Participants: QI team: nurse practitioner, physicians, social workers,
medical assistants, pharmacist
Workshop presenters: nurse practitioner, physicians, therapists
Workshop participants: nurses, physicians, social workers, &
‘other’ healthcare workers

Attitude
11.15

Limitations:
* rural setting in Maine & small data set (N = 13) lends caution to generalization of
results
* short-term effects may not translate long-term
* unknown if stigma reduction affects healthcare professional behavior
* # of prescribers in this project was too small to determine willingness to prescribe
buprenorphine
* OMS-HC: validated instrument designed to measure mental illness-related stigma
in Canada, not OUD-related stigma in the United States

12.77

Disclosure
10.77

11

Social Distance
8.62

Intervention: two 2-hour participatory stigma-reduction workshops held,
one year apart, at two hospitals in Waldo and Knox counties in Maine in
collaboration with the FQHC. Workshops used social contact methods (i.e.,
live-person testimonies) to target 4 roots of healthcare provider-related
stigma (9):
1. pessimistic views about likelihood of recovery (live first-person
testimonies of persons in recovery show that healthcare professional actions
do matter)
2. seeing opioid use disorder before the person (person-first discussed and
modeled)
3. lack of competence and confidence (skills taught about ‘what to say’ and
‘what to do’ through participatory skits / role play)
4. lack of awareness of one’s own biases (‘myth-busting’ and ‘words matter’
discussed and modeled)

pre- & 6-12 weeks post-intervention / 4 variables:
* total stigma score
* attitude toward those with OUD
* willingness to seek help if one personally had OUD
* desire for social distance from those with OUD
Additional question: if you are a physician or NP/PA, would you be willing to obtain
the X waiver to prescribe buprenorphine?

30.54

Pre

Project Aims:
* reduce stigma among healthcare professionals toward patients with OUD
* address learning needs of healthcare professionals around OUD
* increase willingness to provide medications for OUD (MOUD)

Measures:
Quantitative: OMS-HC (revised for OUD) Cronbach’s a 0.79 of 15-item scale
3 subscales (a = 0.67 to 0.68) Likert-type questionnaire
Higher scores denote more stigmatizing attitudes
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Attitude scores from Time 1 (M = 14.54, SD = 5.16) to Time 2 (M =
11.15, SD = 3.40), t (12) = 4.58, p = .001 (two-tailed)
Disclosure/help-seeking scores from Time 1 (M = 12.77, SD = 3.03)
to Time 2 (M = 10.77, SD = 3.75), t (12) = 2.01, p = .067 (two-tailed)
Social distance scores from Time 1 (M = 11.00, SD = 2.35) to Time 2
(M = 8.62, SD = 2.72), t (12) = 3.16, p = .008 (two-tailed)
USM - Institutional Review Board (IRB) approved, 2018, 2019

Conclusions:
Healthcare professional OUD-related stigma can be decreased in rural Maine with
anti-stigma programming modeled after Understanding Stigma. It is unknown if such
short-term programs carry long-term effects for program participants. Its effect on
willingness to treat with MOUD is unknown. More studies with greater numbers of
participants are needed.
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